Get the latest Science News and Discoveries
First‑in‑human study tests gamitrinib designed to disrupt cancer cells’ energy systems - EurekAlert!
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
None
Or read this on Eureka Alert
